China’s IPV Capital and Tsing Capital Lead $26M Round In RayVio Corp

U.S. health and hygiene company RayVio Corp has completed a new funding round of US$26 million led by IPV Capital and China’s Tsing Capital, the company announced in a statement.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets